Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Meissner

Showing results (361-370 of 436) with videos related to

Pageof 44
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2020
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System AtrophyWassilios G Meissner, Anne Pavy-Le Traon, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2020
Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's DiseaseIoanna Markaki, Sofia Bergström, Panagiota Tsitsi, et al.
The Journal of Clinical Investigation|July 2, 2014
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcomeEric G Meissner, David Wu, Anu Osinusi, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|July 29, 2025
Enhancing Cardiovascular Health in Southeastern United States for Underrepresented Racial and Ethnic Minorities With HIV: A Qualitative Inquiry Using the Health Belief ModelCharles Muiruri, Carrie Dombeck, Amy Corneli, et al.
JACC. Advances|October 28, 2025
Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIVElizabeth A Kobe, Robert M Clare, Karen Chiswell, et al.
Movement Disorders Clinical Practice|April 20, 2026
Continuous Apomorphine Infusion in Multiple System Atrophy Real-World Insights From a French Nationwide Retrospective CohortSimon Lamy, Frederique Leh, Alexandra Foubert-Samier, et al.
Frontiers in Aging Neuroscience|June 26, 2026
Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson's disease and aging cohortsEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.
Neurobiology of Disease|July 21, 2018
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophyMiguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivativesRobert J Watson, Daniel R Allen, Helen L Birch, et al.
Journal of the American Heart Association|March 7, 2025
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United StatesMatthew S Durstenfeld, C Larry Hill, Robert M Clare, et al.
Pageof 44

Showing results (361-370 of 436) with videos related to

Sort By:
Pageof 44
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2020
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System AtrophyWassilios G Meissner, Anne Pavy-Le Traon, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2020
Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's DiseaseIoanna Markaki, Sofia Bergström, Panagiota Tsitsi, et al.
The Journal of Clinical Investigation|July 2, 2014
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcomeEric G Meissner, David Wu, Anu Osinusi, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|July 29, 2025
Enhancing Cardiovascular Health in Southeastern United States for Underrepresented Racial and Ethnic Minorities With HIV: A Qualitative Inquiry Using the Health Belief ModelCharles Muiruri, Carrie Dombeck, Amy Corneli, et al.
JACC. Advances|October 28, 2025
Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIVElizabeth A Kobe, Robert M Clare, Karen Chiswell, et al.
Movement Disorders Clinical Practice|April 20, 2026
Continuous Apomorphine Infusion in Multiple System Atrophy Real-World Insights From a French Nationwide Retrospective CohortSimon Lamy, Frederique Leh, Alexandra Foubert-Samier, et al.
Frontiers in Aging Neuroscience|June 26, 2026
Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson's disease and aging cohortsEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.
Neurobiology of Disease|July 21, 2018
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophyMiguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivativesRobert J Watson, Daniel R Allen, Helen L Birch, et al.
Journal of the American Heart Association|March 7, 2025
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United StatesMatthew S Durstenfeld, C Larry Hill, Robert M Clare, et al.
Pageof 44